Winslow Capital Management, LLC Biogen Inc. Transaction History

Winslow Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $1,030 - $1,227	-4 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $193 Million - $273 Million	-742,654 Reduced 100.0%	4 $1,000
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $18.5 Million - $20.7 Million	59,986 Added 8.79%	742,658 $237 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $192 Million - $225 Million	682,672	682,672 $214 Million

1,007

131M

1.77M

2.34M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Winslow Capital Management, LLC with notifications on news.